
Problem statement
Market access and commercial teams need a current read on payer coverage, formulary status, and reimbursement trends to plan launches and pricing, but that intelligence is scattered across payer bulletins, claims data, and internal trackers. Build a payer analytics dashboard that consolidates payer and formulary data into one view so commercial teams can track coverage trends and react to payer policy changes faster.
One-pager
Payer IQ
A Weighted Scoring Prototype for Regional Payer Prioritization
1. What the Prototype Is About
Payer IQ is a quantitative, multi-factor scoring model that evaluates and ranks regional payers based on market opportunity, patient need, and operational feasibility of access. It converts seven weighted data inputs — covered lives, disease prevalence, target patient population, product utilization potential, geographic concentration, provider density, and unmet need — into a single, standardized Market Access Priority Score (0–100) for each payer, with an accompanying tier classification (Tier 1–3).
2. Key Problem It Addresses
Market access, contracting, and field teams currently prioritize regional payer engagement using fragmented data, inconsistent criteria, and qualitative judgment. This creates three risks: resources are spread evenly rather than where opportunity is greatest, prioritization decisions are difficult to defend or replicate across teams, and emerging or overlooked regional payers with high potential can be missed entirely. |
3. Key Features
Standardized, weighted scoring — seven factors combined into one comparable, defensible priority score across all regional payers. | Fully dynamic model— built on live formulas; updating source data or factor weights automatically recalculates rankings. |
Editable weighting framework —weights can be adjusted centrally to reflect shifting strategic priorities without rebuilding the model. | Tiering for resource allocation — payers are automatically classified into Tier 1–3 to guide account-management intensity. |
Transparent, sourced methodology — each input is mapped to a recommended real-world data source (CMS, claims data vendors, formulary databases, etc.) for straightforward transition from prototype to production. |
4. Expected Business Impact
Sharper resource allocation — field, contracting, and account-management effort directed to the payers with the greatest combined opportunity and feasibility. | Faster, more consistent decisions — a shared, transparent scoring standard replaces ad hoc, team-by-team prioritization. |
Improved contracting outcomes — earlier identification of high-unmet-need, high-utilization-potential payers strengthens the case for value-based agreements. | Scalable across products and geographies — the same framework can be reapplied as new products launch or new regions are evaluated, with minimal rebuild effort. |